Andreas M Bucher1, Jens Kleesiek2. 1. Institut für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Frankfurt am Main, Theodor-Stern Kai 7, 60590, Frankfurt am Main, Deutschland. AndreasMichael.Bucher@kgu.de. 2. Translationale bildgestützte Onkologie, Institut für KI in der Medizin (IKIM), Universitätsmedizin Essen, Essen, Deutschland.
Abstract
BACKGROUND: Artificial intelligence (AI) has the potential to fundamentally change medicine within the coming decades. Radiological imaging is one of the primary fields of its clinical application. OBJECTIVES: In this article, we summarize previous AI developments with a focus on oncological radiology. Based on selected examples, we derive scenarios for developments in the next 10 years. MATERIALS AND METHODS: This work is based on a review of various literature and product databases, publications by regulatory authorities, reports, and press releases. CONCLUSIONS: The clinical use of AI applications is still in an early stage of development. The large number of research publications shows the potential of the field. Several certified products have already become available to users. However, for a widespread adoption of AI applications in clinical routine, several fundamental prerequisites are still awaited. These include the generation of evidence justifying the use of algorithms through representative clinical studies, adjustments to the framework for approval processes and dedicated education and teaching resources for its users. It is expected that use of AI methods will increase, thus, creating new opportunities for improved diagnostics, therapy, and more efficient workflows.
BACKGROUND: Artificial intelligence (AI) has the potential to fundamentally change medicine within the coming decades. Radiological imaging is one of the primary fields of its clinical application. OBJECTIVES: In this article, we summarize previous AI developments with a focus on oncological radiology. Based on selected examples, we derive scenarios for developments in the next 10 years. MATERIALS AND METHODS: This work is based on a review of various literature and product databases, publications by regulatory authorities, reports, and press releases. CONCLUSIONS: The clinical use of AI applications is still in an early stage of development. The large number of research publications shows the potential of the field. Several certified products have already become available to users. However, for a widespread adoption of AI applications in clinical routine, several fundamental prerequisites are still awaited. These include the generation of evidence justifying the use of algorithms through representative clinical studies, adjustments to the framework for approval processes and dedicated education and teaching resources for its users. It is expected that use of AI methods will increase, thus, creating new opportunities for improved diagnostics, therapy, and more efficient workflows.
Entities:
Keywords:
Commercial software; Deep learning; Digital transformation; Machine learning; Regulatory affairs
Authors: Benjamin H Kann; Reid Thompson; Charles R Thomas; Adam Dicker; Sanjay Aneja Journal: Oncology (Williston Park) Date: 2019-02-15 Impact factor: 2.990
Authors: Michelle D Bardis; Roozbeh Houshyar; Peter D Chang; Alexander Ushinsky; Justin Glavis-Bloom; Chantal Chahine; Thanh-Lan Bui; Mark Rupasinghe; Christopher G Filippi; Daniel S Chow Journal: Cancers (Basel) Date: 2020-05-11 Impact factor: 6.639
Authors: William D Dunn; Hugo J W L Aerts; Lee A Cooper; Chad A Holder; Scott N Hwang; Carle C Jaffe; Daniel J Brat; Rajan Jain; Adam E Flanders; Pascal O Zinn; Rivka R Colen; David A Gutman Journal: J Neuroimaging Psychiatry Neurol Date: 2016-07-20
Authors: Myura Nagendran; Yang Chen; Christopher A Lovejoy; Anthony C Gordon; Matthieu Komorowski; Hugh Harvey; Eric J Topol; John P A Ioannidis; Gary S Collins; Mahiben Maruthappu Journal: BMJ Date: 2020-03-25